Physician profile
Paul E Buse
NPI 1114993664
$768.11
in general payments reported to CMS, 2019-2025
9 companies · $14.04 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $145 · 2021: $138 · 2022: $305 · 2023: $99.14 · 2024: $66.51 · 2025: $14.04.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $179.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $145.00 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $138.09 | 2021 | |
| Genzyme Corporation | $135.85 | 2022-2025 | |
| Medtronic, INC. | $135.28 | 2022 | |
| Abbvie INC. | $126.66 | 2022-2023 | Rinvoq, Humira, Skyrizi |
| Phathom Pharmaceuticals, INC. | $27.58 | 2024 | Voquezna |
| Ipsen Biopharmaceuticals, INC | $25.03 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $20.72 | 2022 | |
| Capsovision, INC. | $13.90 | 2024 | Capsocam Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Buse listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.